Invest $7,000 in This Dividend Stock for Immense Passive Income

There’s one sector that’s due to continue seeing a massive rise, and that’s healthcare. And this dividend stock is a top choice.

| More on:
telehealth stocks

Image source: Getty Images

When it comes to dividend stocks, monthly income can be a top way to earn income even if the market is volatile. If you’re looking for a reliable dividend stock to add to your portfolio for long-term monthly passive income, Extendicare (TSX:EXE) is one to seriously consider. With a solid history in the healthcare industry, particularly in senior care, Extendicare offers both stability and consistent payouts. This reliability makes it a standout choice for passive income investors.

Into earnings

The dividend stock’s recent earnings report for Q2 2024 highlighted robust performance, with revenue growing by 13.3% year over year. Net income also skyrocketed by an impressive 1,227%, thus signalling management’s success in navigating a post-pandemic recovery while maintaining strong cost control measures. Return on equity sits at a stunning 60%, indicating the company’s ability to turn investments into profits efficiently. This is a great sign for long-term investors.

However, the stock is down from its 52-week highs, with a 200-day moving average of $7.69. While this may seem concerning at first, it’s important to recognize that much of the decline can be attributed to broader market volatility, especially in healthcare sectors impacted by inflation and rising labour costs. Management has been proactive, focusing on increasing efficiency and exploring new growth areas like home health care, which should mitigate the risks over time.

One of Extendicare’s key strategies has been a shift toward expanding its home healthcare services. This is becoming increasingly popular as more seniors prefer aging at home. The focus not only taps into a growing market but also positions the company for continued revenue growth. This pivot also reduces the company’s reliance on traditional long-term care facilities, which have seen more challenges post-pandemic.

What you get now

Looking ahead, the dividend stock is expected to maintain its consistent dividend payouts. All thanks to a stable revenue stream and a commitment to returning value to shareholders. Management continues to invest in technology and expand services. So there’s potential for revenue to keep growing at a healthy pace. These moves suggest that Extendicare is building a resilient business model that can weather short-term headwinds.

Meanwhile, the dividend stock has been delivering monthly dividends at an annual rate of $0.48, yielding around 5.14%. This makes it appealing for those looking to maximize cash flow without waiting for quarterly payouts. The dividend stock’s long-standing business in senior living and home healthcare services has been bolstered by a growing demand for these services, especially with Canada’s aging population, setting up a promising future for the stock.

For investors seeking a steady income stream with a focus on the long term, Extendicare offers the best of both worlds. Its current dividend yield is attractive, and its proactive approach to growth and efficiency puts it in a strong position for the future. While it’s not without risks, such as labour cost pressures, the dividend stock’s strong financials and management strategy provide confidence.

Bottom line

All considered, Extendicare is a top pick for those seeking monthly passive income from dividends. Its attractive yield, coupled with sound management and a promising future, make it a standout option in the healthcare sector. In fact, $7,000 could create immense passive income from dividends and should shares climb back to all-time highs.

COMPANYRECENT PRICENUMBER OF SHARESDIVIDENDTOTAL PAYOUTFREQUENCYINVESTMENT
EXE – now$9.35749$0.48$359.52monthly$7,000
EXE – highs$10.35749$0.48$359.52monthly$7,752.15

Now you have $359.52 in dividends and $752.15 in returns for $1,111.67 in passive income! With the company’s commitment to growth and efficiency, this stock could offer both reliable income and potential capital appreciation for long-term investors.

Should you invest $1,000 in Metro right now?

Before you buy stock in Metro, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Metro wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Dividend Stocks

Doctor talking to a patient in the corridor of a hospital.
Dividend Stocks

This Dividend King Paying 7.5% in Monthly Income Is a Must-Have

This high-yield TSX stock might not be a textbook Dividend King, but its reliable monthly payouts and improving financials make…

Read more »

path road success business
Dividend Stocks

How to Invest $50,000 of Tax-Free Cash as Canada-US Trade Uncertainty Escalates

Few Canadian stocks are as easy a choice as this one, making it perfect during volatile periods.

Read more »

monthly desk calendar
Dividend Stocks

How I’d Generate $200 in Monthly Income With a $7,000 Investment

Want to establish $200 in monthly income (or even more?) Here's an easy way to start today that will provide…

Read more »

Printing canadian dollar bills on a print machine
Dividend Stocks

Got $25,000? Turn it Into $250,000 in a TFSA as the Canadian Dollar Rises

Investing doesn't have to be risky or difficult, especially with this top stock.

Read more »

A woman shops in a grocery store while pushing a stroller with a child
Dividend Stocks

Where Will Loblaw Be in 3 Years?

Loblaw (TSX:L) stock could be a stellar performer as tariffs and headwinds move in on Canada's economy.

Read more »

customer uses bank ATM
Dividend Stocks

Where Will National Bank Be in 5 Years?

National Bank of Canada (TSX:NA) stock still looks like a great deal at these levels.

Read more »

A worker overlooks an oil refinery plant.
Dividend Stocks

The Smartest Industrial Stock to Buy With $3,000 Right Now

Aecon is a value stock that's benefiting from strong infrastructure spending today and in the years to come.

Read more »

chart reflected in eyeglass lenses
Dividend Stocks

This Stock Down 30% Could Be the Bargain of the Decade

With this impressive Canadian growth stock trading 30% off its 52-week high, it might be the best bargain we've seen…

Read more »